Gelatin and lipidoid integrate to create <i>gelasomes</i> to enhance siRNA delivery with low toxicity.

ABSTRACT: RNAi therapeutics possess the potential to cure many uncurable human diseases. For instance, RNAi therapeutics using liposomes showed remarkable survival benefits in patients with liver diseases. However, the extension of liposomes to deliver RNA to cure other ailments has largely been unsuccessful. Therefore, researchers are focusing on designing and testing different combinations of materials for versatile RNA delivery applications. Yet, an efficient and safe RNA delivery platform has not been identified. In this work, we have developed a new class of RNA-delivery vehicle called "Gelasomes," using an incongruous combination of gelatin and lipidoid to exploit each material's unique properties while overcoming their inherent limitations. The low in vivo toxicity of Gelasomes is attr

SUBMITTER: Gangula A 

PROVIDER: S-EPMC11558258 | biostudies-literature | 2024 Oct

REPOSITORIES: biostudies-literature